AbbVie's Venetoclax patent bid in India fails after invention ruled obvious
By Freny Patel ( January 2, 2026, 08:37 GMT | Insight) -- AbbVie Ireland has lost its bid for an Indian patent for the cancer drug Venetoclax after the Controller of Patent ruled the claimed invention obvious. AbbVie Ireland has seen its patent application for the cancer drug Venetoclax refused by the Indian Patent Office....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.